1. Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials. Issue 32 (30th July 2022) Authors: Sadoff, Jerald; Le Gars, Mathieu; Brandenburg, Boerries; Cárdenas, Vicky; Shukarev, Georgi; Vaissiere, Nathalie; Heerwegh, Dirk; Truyers, Carla; de Groot, Anne Marit; Jongeneelen, Mandy; Kaszas, Krisztian; Tolboom, Jeroen; Scheper, Gert; Hendriks, Jenny; Ruiz-Guiñazú, Javier; Struyf, Frank; Van H... Journal: Vaccine Issue: Volume 40:Issue 32(2022) Page Start: 4403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector–based COVID‐19 vaccine. Issue 1 (11th June 2022) Authors: Le Gars, Mathieu; Hendriks, Jenny; Sadoff, Jerald; Ryser, Martin; Struyf, Frank; Douoguih, Macaya; Schuitemaker, Hanneke Journal: Immunological reviews Issue: Volume 310:Issue 1(2022) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of Preexisting Anti–Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 Vaccine . (16th April 2022) Authors: Le Gars, Mathieu; Sadoff, Jerald; Struyf, Frank; Heerwegh, Dirk; Truyers, Carla; Hendriks, Jenny; Gray, Glenda; Grinsztejn, Beatriz; Goepfert, Paul A; Schuitemaker, Hanneke; Douoguih, Macaya Journal: Journal of infectious diseases Issue: Volume 226:Number 6(2022) Page Start: 979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials. (4th December 2021) Authors: Le Gars, Mathieu; Sadoff, Jerald; Jongeneelen, Mandy; Heerwegh, Dirk; Shukarev, Georgi; Truyers, Carla; de Groot, Anne Marit; Scheper, Gert; Hendriks, Jenny; Brandenburg, Boerries; Struyf, Frank; Van Hoof, Johan; Douoguih, Macaya; Schuitemaker, Hanneke Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials. (4th December 2021) Authors: Le Gars, Mathieu; Sadoff, Jerald; Jongeneelen, Mandy; Heerwegh, Dirk; Shukarev, Georgi; Truyers, Carla; de Groot, Anne Marit; Scheper, Gert; Hendriks, Jenny; Brandenburg, Boerries; Struyf, Frank; Van Hoof, Johan; Douoguih, Macaya; Schuitemaker, Hanneke Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Quantifying Antibody Persistence After a Single Dose of COVID‐19 Vaccine Ad26.COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach. Issue 2 (9th December 2022) Authors: Dari, Anna; Boulton, Muriel; Neyens, Martine; Le Gars, Mathieu; Valenzuela, Belén; Shukarev, Georgi; Cárdenas, Vicky; Ruiz‐Guiñazú, Javier; Sadoff, Jerald; Hoetelmans, Richard M. W.; Ruixo, Juan José Pérez Journal: Clinical pharmacology & therapeutics Issue: Volume 113:Issue 2(2023) Page Start: 380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age. Issue 5 (30th November 2022) Authors: Ong-Lim, Anna Lisa; Shukarev, Georgi; Trinidad-Aseron, Mitzi; Caparas-Yu, Delia; Greijer, Astrid; Duchene, Michel; Scheper, Gert; van Paassen, Vitalija; Le Gars, Mathieu; Cahill, Conor P.; Schuitemaker, Hanneke; Douoguih, Macaya; Jacquet, Jeanne-Marie Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, reactogenicity, and immunogenicity of Ad26.COV2.S: Results of a phase 1, randomized, double-blind, placebo-controlled COVID-19 vaccine trial in Japan. Issue 9 (24th February 2023) Authors: Tsuchiya, Yumi; Tamura, Hiroshi; Fujii, Koji; Numaguchi, Hirotaka; Toyoizumi, Kiichiro; Liu, Tina; Le Gars, Mathieu; Cárdenas, Vicky; Eto, Takashi Journal: Vaccine Issue: Volume 41:Issue 9(2023) Page Start: 1602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗